Though asbestos exposure causes thousands of lung cancer cases each year, lawsuits aimed at getting justice from the asbestos companies that caused the disease get less attention and are harder to win than mesothelioma claims. While both diseases come from inhaling asbestos fibers, lung cancer victims face unique legal challenges that sometimes result in lower compensation. Understanding these differences is essential for anyone diagnosed with asbestos-related lung cancer who is considering legal action.
Asbestos Lung Cancer vs. Mesothelioma
The biggest differences between asbestos lung cancer and mesothelioma involve where the disease develops and how clearly asbestos can be blamed for it. Mesothelioma is a rare cancer that develops in the protective lining surrounding the lungs, abdomen, or heart. Because asbestos exposure is the only known cause of mesothelioma, a diagnosis is accepted as proof of asbestos exposure. That makes these cases more easily proven in court, but asbestos lung cancer develops in the lung tissue itself and can result from multiple causes. Smoking, air pollution, radon exposure, exposure to chemicals in the workplace, and even genetic factors can all contribute to lung cancer. This overlap is what creates the legal challenge: Proving that asbestos, rather than another risk factor, caused the disease.
Doctors generally can’t distinguish asbestos-related lung cancer from lung cancer caused by other factors. The cancer cells look the same under a microscope, and symptoms like persistent cough, chest pain, shortness of breath, and weight loss are the same as in lung cancer from any source. This similarity makes it hard to meet the legal requirements of causation.
The Causation Challenge in Lung Cancer Lawsuits
The biggest obstacle in asbestos lung cancer lawsuits is making it clear that asbestos exposure was a significant contributing factor to the disease developing. Attorneys representing asbestos companies can argue that smoking or other risk factors, not asbestos, caused the victim’s lung cancer. This argument is especially hard to counter if the lung cancer victim was also a smoker, which applies to many victims.[1]
These challenges make medical evidence critical. Victims need to show that they experienced significant asbestos exposure. This is typically done through detailed documentation of work history that shows prolonged contact with asbestos-containing materials. If the lung cancer victim has also been diagnosed with asbestosis or pleural plaques, that helps too, because those conditions are linked to asbestos exposure and are visible on imaging scans. Expert testimony from pulmonologists and pathologists is often essential because they can speak to the relationship between the patient’s exposure history and their cancer diagnosis.
Even with strong medical evidence, lung cancer cases can face skepticism that mesothelioma cases don’t. When multiple risk factors exist, juries may question whether asbestos truly caused the disease. This doubt can impact a jury’s decision about compensation. By some estimates, mesothelioma settlements are worth four to six times as much as lung cancer settlements.
Compensation Ranges for Asbestos Lung Cancer
To understand potential compensation amounts for an asbestos lung cancer case, you need to start by understanding that they generally result in lower payouts than the substantial amounts you’ve heard about mesothelioma victims receiving. Still, significant recovery is common in cases with strong evidence.
Average settlements for asbestos lung cancer typically range from $100,000 to $400,000. These settlements usually involve multiple defendants, with each contributing a portion based on their liability. Cases with clear exposure history, minimal competing risk factors, and compelling medical evidence can lead to settlements exceeding $500,000.
Lung cancer cases go to trial in fewer than 5% of cases, but when it happens, positive verdicts tend to be substantially higher. Typical awards range from $2 million to $5 million. These amounts represent the upper end of what juries award, and verdicts and awards are often appealed. This can delay payment for years.
High-end verdicts do occur but represent outliers rather than typical outcomes. In 2023, a New York jury awarded $38 million in an asbestos lung cancer case, but it’s important to keep in mind that exceptional verdicts usually involve particularly egregious exposure circumstances, defendants with clear knowledge of asbestos dangers, and compelling evidence linking exposure to disease.
Compensation Options for Asbestos Lung Cancer Victims
The compensation option an asbestos lung cancer victim chooses significantly affects the amount they will receive. Most victims pursue multiple avenues at the same time to maximize their total.
Lawsuits: Settlements and Verdicts
Filing an individual lawsuit against the asbestos companies responsible for asbestos exposure is the method most asbestos lung cancer victims choose for compensation. These cases typically name multiple defendants, and each one has the potential for being ordered to pay a portion of the damages.
The process begins with identifying all potential defendants through a detailed investigation of the victim’s work history and exposure. This investigation generally identifies between 10 and 30 or more companies. Based on the strength of the case, many of these defendants choose to settle individually. One might settle for $75,000, another for $50,000, a third for $125,000, and so forth, until the total reaches the average settlement range. Cases with particularly strong evidence may yield larger amounts.
The advantage of filing a lawsuit lies in the potential for maximum recovery, especially when it’s clear that a company is to blame. The disadvantages include the time required and the uncertainty of a trial’s outcome if settlement negotiations fail. On top of that, defendants routinely appeal large verdicts, and this can significantly extend the process.
Asbestos Trust Fund Claims
Starting in the 1980s, major asbestos manufacturers and suppliers faced thousands of lawsuits and were held responsible for billions of dollars in claims. Many of them filed for bankruptcy protection, and courts required them to establish trust funds to compensate current and future asbestos victims. These trusts now number approximately 60, with over $30 billion in remaining assets as of 2025.
Each trust has its own schedule of diseases and assigns base values to each diagnosis. For lung cancer, a trust might assign a base value of $200,000. However, trusts rarely pay the full scheduled amount due to concerns about preserving funds for future claimants. Instead, they apply a payment percentage, typically ranging from 5% to 25% of the scheduled value. This limits the total recovery from trust claims.
Still, trust funds offer relatively quick payouts with no court involvement required. This speed can be crucial, and trust funds provide compensation even when the responsible company no longer exists. That’s not true of a lawsuit.
Most lung cancer victims file claims with multiple trusts, and when their awards are combined, they can reach $100,000 to $200,000. The process requires detailed documentation of exposure history, medical records confirming the diagnosis, and evidence linking the disease to asbestos exposure. These claims may face additional scrutiny regarding causation, especially if the victim smoked.
Combined Approach
Because lung cancer cases generally result in lower compensation amounts, many experienced asbestos attorneys will pursue multiple payment sources at the same time. This strategy, combining individual lawsuits against companies that still exist with trust fund claims, ensures that all potential defendants are identified and claims are submitted to all applicable trusts.
Current Trends in Asbestos Litigation
There are important trends that victims may want to consider when weighing their compensation options. According to the KCIC Asbestos Report 2024 Midyear Update, the number of asbestos lung cancer cases being filed is increasing, even as overall asbestos filings are staying roughly the same and the number of mesothelioma cases is declining.[”2”]
This shift suggests that more asbestos lawyers are taking on the challenge of proving causation in lung cancer cases, possibly due to improved medical evidence and expert testimony linking asbestos exposure to lung cancer, even in the presence of other risk factors. The trend may also be a result of growing recognition among exposed workers that lung cancer can qualify for asbestos compensation.
Types of Asbestos Lung Cancer
The specific type of lung cancer an asbestos exposure victim has been diagnosed with can have a big effect on the success of a legal claim, though causation challenges apply across all types. Asbestos-related lung cancer generally falls into the same categories as lung cancer that originates from other causes.[3]
- Non-small cell lung cancer (NSCLC) accounts for approximately 80% to 85% of all lung cancers, including those caused by asbestos. NSCLC includes several subtypes: adenocarcinoma, which develops in the outer regions of the lungs; squamous cell carcinoma, which forms in the central part of the lungs near the bronchi; and large cell carcinoma, a less common, fast-growing type. Studies suggest that asbestos exposure may be more strongly associated with certain subtypes, though all types can result from asbestos exposure.
- Small cell lung cancer (SCLC) represents about 10% to 15% of lung cancers and grows more aggressively than NSCLC. While less common, SCLC can also result from asbestos exposure, particularly in workers with heavy occupational contact with asbestos materials.
From a legal perspective, the specific cancer type matters less than being able to prove that asbestos exposure caused it. To help, medical experts are often called in to testify about typical latency periods, the pattern of exposure, and the presence of asbestos-related lung abnormalities, but the cancer subtype itself rarely determines case viability.
The Importance of Experienced Legal Representation
For workers who developed lung cancer after years of asbestos exposure, taking legal action provides both compensation and justice, as successful claims lead to accountability for the companies that exposed them to known dangers. The complexity of asbestos lung cancer cases makes it essential that victims put themselves in the hands of experienced attorneys who regularly handle asbestos litigation. These knowledgeable professionals understand the medical evidence required, know how to counter causation defenses, maintain relationships with qualified medical experts, and have experience in navigating both the court system and trust fund processes.
They also understand the strategic decisions that affect compensation. They know which asbestos companies to settle with and when to push toward trial; how to maximize trust fund recoveries while pursuing litigation; and how to present lung cancer cases effectively to juries despite the many challenges.
Though there are significant differences between asbestos lung cancer cases and lawsuits filed by mesothelioma victims, both are a result of asbestos company negligence. What matters most is not comparing compensation but rather ensuring that lung cancer victims receive fair compensation for the harm that asbestos exposure caused them.
References
View All References
